A new smartphone app has been launched for free on the iTunes App Store called “MyAsthma.” The app, developed by GlaxoSmithKline (GSK) along with lung experts from the Nottingham Respiratory Research Unit, helps people with asthma track their condition and all the factors that can trigger it.
With millions of people affected by asthma, and around someone experiencing a potentially life-threatening asthma attack every 10 seconds, the MyAsthma App helps users monitor and track their condition by showing the current environmental information to analyze factors that could potentially trigger their asthma. It even allows caretakers to track the asthma conditions of up to 5 of their patients. It also comes with the clinically validated Control TestTM (ACT) or Childhood Asthma Control Test (C-ACT) to monitor their asthma control every 30 days.
- Current environmental information — air temperature, pollution and pollen levels.
- A record of asthma attacks and symptoms including date, triggers and inhaler use.
- A medication track.
- Peak flow or spirometry readings record.
- Sharing access of personal asthma summary with healthcare professionals.
- Links to Apple Health, leading fitness trackers and other health apps.
Dr Dominick Shaw, Associate Clinical Professor and lead researcher on the app says that “This app has the potential to be a significant step forward in asthma self-management. It will help people take control of their own asthma by improving their understanding of what triggers poor asthma control. Good self-management in asthma has many benefits and is associated with improved outcomes, including fewer attacks, unplanned primary care visits and hospital admissions.”
When asked about GSK’s collaboration between Nottingham Respiratory Research Unit to develop MyAsthma, Kai Gait, Global Digital Director at GSK, said that “GSK’s goal is to help all people with asthma live every breath. We believe that enabling patients to take control of their disease is one of the best ways to help them achieve improved health so that asthma doesn’t need to stand in their way.”
Source: Medical Design Technology
“With MyAsthma our aim has been to use advances in smartphone and connected technologies to advance asthma patients’ understanding of their condition, but also to help them share their information with their healthcare team. GSK is proud to have partnered with the Nottingham research team to develop the first CE marked medical device application for people with asthma, demonstrating our commitment to furthering the understanding of respiratory diseases.” He adds
My asthma has been shortlisted for the AXA PPP Healthcare Health Tech & You Awards 2017. The awards give recognition to those who developed health technology that has the potential to or is already making a difference to people’s lives. The winners will be announced on the 27th of April.